Clinical trial

Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

NCT07210125

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2025-09-16

PhasePHASE4

Study timeline

Study start (actual)2025-09-16Date precision: day

Registry last updated2026-04-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Interventions

Lenacapavir long-actingDRUG

Standard of Care (SOC)OTHER

Sponsors & collaborators

Kelley-Ross & Associates, Inc.lead sponsor

Gilead Sciencescollaborator

Mapped research locations

SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07210125 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.